TRIB3 and colorectal cancer: Previous studies based on several cancer cells and animal models had found that the inactivation of TRIB3 regulated Akt pathway and enhanced tumor development (Salazar et al., 2015), while FABP1 was significantly downregulated in some subtypes of colorectal cancer due to the influence of immune microenvironment (Wood et al., 2017).